vs
Side-by-side financial comparison of Nano Dimension Ltd. (NNDM) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $57.8M, roughly 1.1× Nano Dimension Ltd.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -171.1%, a 210.5% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $-21.1M).
Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
NNDM vs SLNO — Head-to-Head
Income Statement — Q4 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.8M | $66.0M |
| Net Profit | $-98.8M | $26.0M |
| Gross Margin | 43.1% | 98.3% |
| Operating Margin | -155.1% | 33.5% |
| Net Margin | -171.1% | 39.4% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 134.0% |
| EPS (diluted) | $-0.45 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $66.0M | ||
| Q2 25 | — | $32.7M | ||
| Q4 24 | $57.8M | — | ||
| Q2 24 | $28.4M | — | ||
| Q2 23 | $29.7M | — |
| Q3 25 | — | $26.0M | ||
| Q2 25 | — | $-4.7M | ||
| Q4 24 | $-98.8M | — | ||
| Q2 24 | $-79.2M | — | ||
| Q2 23 | $12.6M | — |
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q4 24 | 43.1% | — | ||
| Q2 24 | 45.8% | — | ||
| Q2 23 | 44.0% | — |
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | -20.0% | ||
| Q4 24 | -155.1% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | -14.4% | ||
| Q4 24 | -171.1% | — | ||
| Q2 24 | -279.4% | — | ||
| Q2 23 | 42.3% | — |
| Q3 25 | — | $0.47 | ||
| Q2 25 | — | $-0.09 | ||
| Q4 24 | $-0.45 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q2 23 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $317.2M | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $860.0M | $494.8M |
| Total Assets | $902.5M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q4 24 | $317.2M | — | ||
| Q2 24 | $231.8M | — | ||
| Q2 23 | $454.6M | — |
| Q3 25 | — | $494.8M | ||
| Q2 25 | — | $240.1M | ||
| Q4 24 | $860.0M | — | ||
| Q2 24 | $870.3M | — | ||
| Q2 23 | $1.1B | — |
| Q3 25 | — | $599.9M | ||
| Q2 25 | — | $332.3M | ||
| Q4 24 | $902.5M | — | ||
| Q2 24 | $911.0M | — | ||
| Q2 23 | $1.2B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.9M | $43.5M |
| Free Cash FlowOCF − Capex | $-21.1M | $43.5M |
| FCF MarginFCF / Revenue | -36.5% | 65.8% |
| Capex IntensityCapex / Revenue | 3.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q4 24 | $-18.9M | — | ||
| Q2 24 | $-30.7M | — | ||
| Q2 23 | $-56.1M | — |
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q4 24 | $-21.1M | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q4 24 | -36.5% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q4 24 | 3.8% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 1.67× | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | -4.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
